Pilot Study to Evaluate the Clinical Utility of Auscultation Software at Remote Locations

Solventum US LLC

Status: Completed

Conditions: Auscultation of Heart and Lungs

Study type: Observational

Funder types: Industry

Identifiers

NCT01138592

05-003041

Details and patient eligibility

About

Primary Objective: Evaluation of the utility of real-time, scope-to-scope communication between commercially-available 3M Littmann Electronic Model 3200 Electronic stethoscopes over a dedicated intranet system for the assessment of patients at remote (satellite) clinic locations by centrally-located (hub) medical providers.

Secondary Objective: Comparison of the accuracy of patient assessment between the remotely located, mid-level presenter with the centrally-located physician or nurse practitioner provider.

Enrollment: 150 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Male and female subjects who are at least 18 years of age
2. Subjects who are scheduled to undergo examination in a telemedicine setting
3. Subjects who are willing to voluntarily sign the compound Informed Consent and the Authorization to Disclose Protected Health Information Form.

Exclusion criteria

1. Subjects who are unwilling to undergo additional examination in a telemedicine setting,
2. Any subject requiring time-critical medical intervention.
3. Any subject who the investigator believes should not be included or is unsuitable for inclusion in the study.

Trial design

150 participants in 1 patient group

Primary Care Patients

Description:

Any patient undergoing a telemedicine evaluation involving auscultation of the heart and lungs.